The naturally occurring bile acid chenodeoxycholate is used clinically at doses of 14-15 mg/kg per day for the dissolution in vivo of small radiolucent gallstones (Bouchier, 1980; Hofmann, 1980; Iser & Sali, 1981). A consequence of chenodeoxycholate administration is that the amount of chenodeoxycholate in human bile increases to 75-90% of biliary bile acids; this occurs at the expense of the other major human bile acids, deoxycholate and cholate (Bouchier, 1980; Iser & Sali, 1981). Several plasma-membrane marker enzymes have been identified in the biles of many mammalian species (Holdsworth & Coleman, 1975; Evans et at., 1976; Coleman et a!., 1979). These enzymes have been shown to be released from the plasma membranes of isolated hepatocytes before the onset of lysis by treatment with bile salts (Billington et al., 1980). Dihydroxy bile salts were more membrane-damaging than trihydroxy bile salts in that they released significant amounts of these enzymes at approx. 10-fold lower concentrations. These results, together with the observation of Mullock et al. (1977) that rat bile 5'-nucleotidase is immunologically identical with the liver enzyme, have led to the suggestion that plasma-membrane enzymes occur in bile as a result of bile salt attack on the plasma membrane in the region of the bile canaliculus (Coleman et al., 1977). Chenodeoxycholate was administered to female Wistar rats (approx. 220g) by gastric intubation for 14 days at two dosages: 90 mg/kg per day [roughtly equivalent to the therapeutic dose in man on the basis of body surface area (Freireich et al., 1966)l and 300mg/kg per day. The bile acid was dissolved in a final volume of 1 ml and control animals were similarly intubated with 1 ml of saline (0.9% NaCl). Bile-duct cannulation was performed while the animals were under pentobarbitone anaesthesia. Bile was collected for 2h on ice and then stored at -20°C until analysed; a 0-2 h collection period was used, since the changes in the composition of rat bile owing to interruption of the enterohepatic circulation are minimal over this time period (Kakis & Yousef, 1978; Godfrey et al., 1981). Alkaline phosphatase (EC 3.1.3.1), alkaline phosphodiesterase I (EC 3.1.4. I), 5'-nucleotidase (EC 3.1.3.5), L-leucine p-naphthylamidase (EC 3.4.1 1.1) and lactate dehydrogenase (EC 1.1.1.27) were assayed in bile samples as described previously (Coleman et al., 1979). Chenodeoxycholate feeding did not significantly alter the bile-flow rate or the total protein concentration of bile, showing that total biliary protein output was unaffected. However, the specific activities of some plasma-membrane marker enzymes in bile from chenodeoxycholate-fed rats was markedly increased (Table 1). Alkaline phosphatase and 5'-nucleotidase were increased 3-fold in rats given 300mg/kg per day. Alkaline phosphodiesterase I activity in bile was unaffected whilst a small but insignificant increase was seen with L-leucine p-naphthylamidase. Lactate dehydrogenase was absent from the biles of both control and chenodeoxycholate-fed rats, showing that these plasma-membrane enzymes were released into bile in the absence of gross cellular damage. Sodium dodecyl sulphate/ Table 1. Spec@ activities of plasma-membrane marker enzymes in bile from control and chenodeoqrholatefed rats